Routine insider onboarding filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Bonuccelli to gauge insider conviction.
Price Chart
Executive Summary
Catherine M. Bonuccelli filed a Form 3 initial statement of beneficial ownership with IRulya Therapeutics Inc., indicating she has become a reporting insider (officer, director, or >10% holder). The filing is a routine administrative requirement for new insiders and contains no transaction or material financial information.
Key Facts
- Form 3 filed by Catherine M. Bonuccelli on 2026-10-19, reporting ownership as of 2026-10-08
- No securities ownership amounts or transaction details disclosed in the filing
- Power of Attorney (Ex-24) authorizes Brigette Roberts and John Militello to execute future Section 16 filings
Financial Impact
No financial impact — no ownership or transaction data reported
Risk Factors
- No material risk identified from this filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0002159407-26-000002 |
| Document: 0002159407-26-000002-index-headers.html | 0002159407-26-000002 |
| Document: 0002159407-26-000002-index.html | 0002159407-26-000002 |
| Document: 0002159407-26-000002.txt | 0002159407-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 144 | $32.83 | awaiting T+20 | — | $31.38 (−4.42%) |
Oct 19, 2026 7d ago | 3 | $40.27 | awaiting T+20 | — | $31.38 (−22.08%) |
Oct 19, 2026 7d ago | 3 | $40.27 | awaiting T+20 | — | $31.38 (−22.08%) |
Oct 19, 2026 7d ago | 3 | $40.27 | awaiting T+20 | — | $31.38 (−22.08%) |
Oct 19, 2026 7d ago | 3 | $40.27 | awaiting T+20 | — | $31.38 (−22.08%) |
Oct 19, 2026 7d ago | 3 | $40.27 | awaiting T+20 | — | $31.38 (−22.08%) |
Oct 19, 2026 7d ago | 8-K | $34.45 | awaiting T+20 | — | $31.38 (−8.91%) |
Oct 14, 2026 12d ago | SC 13G | $33.23 | awaiting T+20 | — | $31.38 (−5.57%) |
Oct 14, 2026 12d ago | SC 13G | $33.23 | awaiting T+20 | — | $31.38 (−5.57%) |
Oct 6, 2026 20d ago | 8-K | $26.72 | awaiting T+20 | — | $31.38 (+17.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers